Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial

NCT02624973 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT02624973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02624973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
Lead sponsor
Haukeland University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 15, 2016
Completion date
June 30, 2030
Enrollment
200 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer